Radiobotics receives regulatory approval for RBfracture in Australia

Registration for RBfracture™ in Australia is a milestone in bringing fracture detection AI for emergency departments and radiology teams.

March 30, 2025 — Copenhagen, Denmark — Radiobotics, a leader in AI-driven musculoskeletal (MSK) radiology solutions, is proud to announce that RBfracture has been successfully registered for use in Australia. This milestone expands access to cutting-edge fracture detection AI for emergency departments and radiology teams further into Oceania.

RBfracture in Australia

RBfracture uses advanced algorithms to automatically detect fractures on standard X-rays, supporting clinicians in improving diagnostic accuracy and reducing the risk of missed fractures — particularly in high-pressure emergency care. RBfracture is already available in New Zealand and has now met the regulatory requirements to support healthcare providers in Australia as well.

Fractures of the wrist, hand, and forearm are among the most frequent injuries seen in Australian emergency departments, particularly in both adult and paediatric patients. By focusing on these high-prevalence areas, RBfracture provides a practical and scalable tool for improving early fracture detection and optimizing clinical workflows.

“We’re proud to bring RBfracture to the Australian market,” said Hege Friesgaard, Head of QA at Radiobotics. “With its proven accuracy and easy integration, this tool can support clinicians in making faster, more confident decisions for trauma patients.”

Radiobotics remains committed to working closely with hospitals, clinicians, and partners across Australia to ensure smooth implementation — from system integration to staff training. RBfracture is designed to fit into existing workflows, helping to accelerate diagnosis and reduce pressure on radiology teams.

RBfracture is now available for installation across eligible healthcare facilities in Australia, joining a growing number of international hospitals already benefiting from Radiobotics’ AI technology.

About Radiobotics

Founded in 2017, Radiobotics, a Medimaps Group company, is an award-winning Danish MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusion.

Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, constraints, is reflected in its close collaboration with leading clinical institutions, including partnering with Oxford University Hospital (OUH) on the world’s first and largest randomised clinical trial evaluating radiology AI in urgent care as well as achieving NICE approval for use in urgent care settings across the NHS.

Media contact
Elyse Sims
Head of Marketing, Radiobotics

Share this press release

Latest news